How are you doing, Dr. Lenfant, on finding a cure for scleroderma?

These people come to us and say, you are giving NIH all the money. What is happening? I do not like to hear talk of long periods of time on appointing steering committees.

Why is it taking so long?

And when do you expect to have a permanent director there?

Does this new test pose real promise to give an easier, better diagnosis of breast cancer?

Thank you very much, Dr. Zerhouni.

I broach the subject of some delicacy now, which has already been communicated to you.

Dr. Penn, the question is, when was SMA selected for this transitional research program?

Well, when will the first grants be awarded?

I would like to have precise answers as to when the program was adopted.

There is an inevitable sense that a full-time director with that authority is necessary to move an institute along at top speed.